CN217886692U - Insulin syringe with needle tip protection function - Google Patents
Insulin syringe with needle tip protection function Download PDFInfo
- Publication number
- CN217886692U CN217886692U CN202220354633.2U CN202220354633U CN217886692U CN 217886692 U CN217886692 U CN 217886692U CN 202220354633 U CN202220354633 U CN 202220354633U CN 217886692 U CN217886692 U CN 217886692U
- Authority
- CN
- China
- Prior art keywords
- needle
- syringe
- support rod
- syringe body
- rod
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 102000004877 Insulin Human genes 0.000 title claims abstract description 21
- 108090001061 Insulin Proteins 0.000 title claims abstract description 21
- 229940125396 insulin Drugs 0.000 title claims abstract description 21
- 238000002347 injection Methods 0.000 claims abstract description 35
- 239000007924 injection Substances 0.000 claims abstract description 35
- 230000001681 protective effect Effects 0.000 claims description 9
- 238000000034 method Methods 0.000 abstract description 9
- 239000000243 solution Substances 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
本实用新型公开了一种具有针尖防护功能的胰岛素注射器,包括针筒体,所述针筒体的一端设有注射针,所述针筒体的一侧设有与针筒体铰接的支撑杆,所述支撑杆的一侧铰接有铰接杆,所述铰接杆的另一端连接定位挂钩,所述针筒体上位于支撑杆的一侧设有多组定位环,所述定位环位于针筒体上靠近注射针的一侧,本实用新型能够通过支撑杆对注射器进行支撑,防止在注射过程中注射针发生偏移,同时可以通过定位挂钩与定位环的配合来调整支撑杆与注射器之间的角度,进而方便对注射器的进针角度进行调节并在调整好进针角度后对其进行定位,防止注射过程中注射针头抖动。
The utility model discloses an insulin injector with a needle tip protection function, which comprises a needle cylinder body, an injection needle is arranged at one end of the needle cylinder body, and a support rod hinged with the needle cylinder body is provided at one side of the needle cylinder body One side of the support rod is hinged with a hinged rod, the other end of the hinged rod is connected to a positioning hook, and multiple sets of positioning rings are arranged on the side of the support rod on the needle cylinder body, and the positioning rings are located on the needle cylinder On the side close to the injection needle, the utility model can support the syringe through the support rod to prevent the injection needle from shifting during the injection process. At the same time, the distance between the support rod and the syringe can be adjusted through the cooperation of the positioning hook and the positioning ring. It is convenient to adjust the needle entry angle of the syringe and position it after adjusting the needle entry angle to prevent the injection needle from shaking during the injection process.
Description
技术领域technical field
本实用新型涉及注射器技术领域,特别是涉及一种具有针尖防护功能的胰岛素注射器。The utility model relates to the technical field of syringes, in particular to an insulin syringe with a needle point protection function.
背景技术Background technique
糖尿病是一组以高血糖为特征的代谢性疾病。高血糖则是由于胰岛素分泌缺陷或其生物作用受损,或两者兼有引起。糖尿病时长期存在的高血糖,导致各种组织,特别是眼、肾、心脏、血管、神经的慢性损害、功能障碍,目前可通过多种治疗手段可以控制好糖尿病,比如病人通过输入胰岛素控制身体的糖份量,胰岛素是由胰脏内的胰岛β细胞受内源性或外源性物质如葡萄糖、乳糖、核糖、精氨酸、胰高血糖素等的刺激而分泌的一种蛋白质激素。胰岛素是机体内唯一降低血糖的激素,同时促进糖原、脂肪、蛋白质合成,糖尿病患者在使用胰岛素治疗时,在进行胰岛素注射时,需要用到注射器。Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is caused by defective insulin secretion or impaired biological action, or both. The long-term high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves. At present, diabetes can be controlled well through a variety of treatment methods. For example, patients can control their body by injecting insulin. Insulin is a protein hormone secreted by the islet β cells in the pancreas when stimulated by endogenous or exogenous substances such as glucose, lactose, ribose, arginine, and glucagon. Insulin is the only hormone that lowers blood sugar in the body, and at the same time promotes the synthesis of glycogen, fat, and protein. When diabetic patients use insulin therapy, they need to use a syringe when injecting insulin.
现有专利申请号为CN202022784578.4的实用新型公开了一种胰岛素注射器。具有筒体、设置在筒体内的推杆、卡接在推杆顶端的胶塞、设置在筒体顶端与其内部连通的针管;所述筒体顶端套有罩住针管的滑动防护帽,设置在滑动防护帽顶端有进液孔。The utility model with the existing patent application number CN202022784578.4 discloses an insulin syringe. It has a cylinder body, a push rod arranged in the cylinder body, a rubber plug clamped on the top of the push rod, and a needle tube arranged at the top of the cylinder body and communicated with the inside; There is a liquid inlet hole at the top of the sliding protective cap.
该实用新型可以防止针套丢失,防止操作人员扎伤,或误伤他人。可以精密过滤药液中5um以上的微粒,减少患者血液污染和血管栓塞的风险,但是仍然存在以下缺点:胰岛素注射器在使用的时候,需要根据具体患者的体型和注射部位以及注射枕头的长度来决定注射时进针的角度,而在选择好进针角度开始注射后注射针在注射过程中也会容易发生偏移,进而无法实现最好的注射效果,同时还加大了患者的痛苦。The utility model can prevent the loss of the needle cover, prevent the operator from being stabbed, or accidentally injuring others. It can precisely filter the particles above 5um in the liquid medicine to reduce the risk of blood contamination and vascular embolism in patients, but there are still the following disadvantages: when using insulin syringes, it needs to be determined according to the body shape of the specific patient, the injection site and the length of the injection pillow. The angle of the needle during injection, and the injection needle will easily shift during the injection process after the injection is started at a good needle insertion angle, so that the best injection effect cannot be achieved, and the pain of the patient is also increased.
实用新型内容Utility model content
为了克服现有技术的不足,本实用新型提供一种具有针尖防护功能的胰岛素注射器,能够通过支撑杆对注射器进行支撑,防止在注射过程中注射针发生偏移,同时可以通过定位挂钩与定位环的配合来调整支撑杆与注射器之间的角度,进而方便对注射器的进针角度进行调节并在调整好进针角度后对其进行定位,防止注射过程中注射针头抖动。In order to overcome the deficiencies of the prior art, the utility model provides an insulin syringe with a needle point protection function, which can support the syringe through a support rod to prevent the injection needle from shifting during the injection process. The angle between the support rod and the syringe can be adjusted through the cooperation of the support rod, so that the needle entry angle of the syringe can be adjusted conveniently and positioned after the needle entry angle is adjusted, so as to prevent the injection needle from shaking during the injection process.
为解决上述技术问题,本实用新型提供如下技术方案:一种具有针尖防护功能的胰岛素注射器,包括针筒体,所述针筒体的一端设有注射针,所述针筒体的一侧设有与针筒体铰接的支撑杆,所述支撑杆的一侧铰接有铰接杆,所述铰接杆的另一端连接定位挂钩,所述针筒体上位于支撑杆的一侧设有多组定位环,所述定位环位于针筒体上靠近注射针的一侧。In order to solve the above technical problems, the utility model provides the following technical solutions: an insulin syringe with a needle point protection function, including a syringe body, an injection needle is provided at one end of the syringe body, and an injection needle is provided at one side of the syringe body. There is a support rod hinged with the needle cylinder body, one side of the support rod is hinged with a hinge rod, the other end of the hinge rod is connected with a positioning hook, and multiple sets of positioning hooks are arranged on the side of the support rod on the needle cylinder body. The positioning ring is located on the side of the syringe body close to the injection needle.
作为本实用新型的一种优选技术方案,所述针筒体的一侧开设有收放槽,所述定位环与支撑杆均位于收放槽内部。As a preferred technical solution of the present invention, a retractable groove is opened on one side of the syringe body, and both the positioning ring and the support rod are located inside the retractable groove.
作为本实用新型的一种优选技术方案,所述收放槽内设有第一铰接座,所述支撑杆通过第一铰接座与针筒体铰接,所述支撑杆上设有第二铰接座,所述铰接杆通过第二铰接座与支撑杆之间铰接。As a preferred technical solution of the present utility model, a first hinged seat is provided in the storage slot, the support rod is hinged to the needle barrel through the first hinged seat, and a second hinged seat is provided on the support rod , the hinged rod is hinged between the second hinged seat and the support rod.
作为本实用新型的一种优选技术方案,所述针筒体内部设有活塞头,所述活塞头的远离注射针的一端固定有活塞杆,所述活塞杆伸出针筒体的外部并连接有推板。As a preferred technical solution of the present utility model, a piston head is arranged inside the syringe body, and a piston rod is fixed on the end of the piston head away from the injection needle, and the piston rod extends out of the syringe body and is connected to There is a push plate.
作为本实用新型的一种优选技术方案,所述支撑杆上远离第一铰接座的一端固定有支撑垫,所述针筒体的外部设有刻度线。As a preferred technical solution of the present invention, a support pad is fixed on the end of the support rod away from the first hinge seat, and a scale line is provided on the outside of the needle cylinder.
作为本实用新型的一种优选技术方案,所述针筒体上位于注射针的一侧外部设有防护套,所述防护套的内部设有橡胶塞。As a preferred technical solution of the present invention, the syringe body is provided with a protective cover on one side of the injection needle, and a rubber stopper is provided inside the protective cover.
与现有技术相比,本实用新型能达到的有益效果是:Compared with the prior art, the beneficial effects that the utility model can achieve are:
本实用新型能够通过支撑杆对注射器进行支撑,防止在注射过程中注射针发生偏移,同时可以通过定位挂钩与定位环的配合来调整支撑杆与注射器之间的角度,进而方便对注射器的进针角度进行调节并在调整好进针角度后对其进行定位,防止注射过程中注射针头抖动。The utility model can support the syringe through the support rod to prevent the injection needle from shifting during the injection process. At the same time, the angle between the support rod and the syringe can be adjusted through the cooperation of the positioning hook and the positioning ring, thereby facilitating the injection of the syringe. Adjust the needle angle and position it after adjusting the needle entry angle to prevent the injection needle from shaking during the injection process.
附图说明Description of drawings
图1为本实用新型的整体外部结构示意图;Fig. 1 is a schematic diagram of the overall external structure of the utility model;
图2为本实用新型的整体结构示意图;Fig. 2 is the overall structural representation of the utility model;
图3为本实用新型中支撑杆打开时的结构示意图;Fig. 3 is a structural schematic diagram when the support rod is opened in the utility model;
图4为本实用新型图3中A处放大图;Fig. 4 is the enlarged view of place A in Fig. 3 of the present utility model;
其中:1、针筒体;2、活塞杆;3、活塞头;4、推板;5、收放槽;6、支撑杆;7、第一铰接座;8、第二铰接座;9、铰接杆;10、定位挂钩;11、支撑垫;12、定位环;13、注射针;14、防护套;15、橡胶塞;16、刻度线。Among them: 1. Needle cylinder body; 2. Piston rod; 3. Piston head; 4. Push plate; 5. Retractable groove; 6. Support rod; 7. First hinged seat; articulated rod; 10, positioning hook; 11, support pad; 12, positioning ring; 13, injection needle; 14, protective sleeve; 15, rubber stopper; 16, scale line.
具体实施方式Detailed ways
为了使本实用新型实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体实施例,进一步阐述本实用新型,但下述实施例仅仅为本实用新型的优选实施例,并非全部。基于实施方式中的实施例,本领域技术人员在没有做出创造性劳动的前提下所获得其它实施例,都属于本实用新型的保护范围。下述实施例中的实验方法,如无特殊说明,均为常规方法,下述实施例中所用的材料、试剂等,如无特殊说明,均可从商业途径得到。In order to make the technical means, creative features, goals and effects of the utility model realized easy to understand, the utility model will be further elaborated below in conjunction with specific examples, but the following examples are only preferred embodiments of the utility model, not all . Based on the examples in the implementation manners, other examples obtained by those skilled in the art without making creative efforts all belong to the protection scope of the present utility model. The experimental methods in the following examples, unless otherwise specified, are conventional methods, and the materials, reagents, etc. used in the following examples, unless otherwise specified, can be obtained from commercial sources.
实施例:Example:
如图2、图3、图4所示,本实用新型提供,一种具有针尖防护功能的胰岛素注射器,包括针筒体1,所述针筒体1的一端设有注射针13,所述针筒体1的一侧设有与针筒体1铰接的支撑杆6,所述支撑杆6的一侧铰接有铰接杆9,所述铰接杆9的另一端连接定位挂钩 10,所述针筒体1上位于支撑杆6的一侧设有多组定位环12,所述定位环12位于针筒体1上靠近注射针13的一侧,所述针筒体1的一侧开设有收放槽5,所述定位环12与支撑杆6均位于收放槽5内部,所述收放槽5内设有第一铰接座7,所述支撑杆6通过第一铰接座7 与针筒体1铰接,所述支撑杆6上设有第二铰接座8,所述铰接杆9 通过第二铰接座8与支撑杆6之间铰接;As shown in Fig. 2, Fig. 3 and Fig. 4, the utility model provides an insulin syringe with a needle point protection function, which includes a
使用本装置时,先转动支撑杆6使其位于收放槽5外,并根据需要的进针角度来调整支撑杆6与针筒体1之间的角度,当确定好两者之间的角度时,再转动铰接杆9带动定位挂钩10转动到合适的位置并挂上定位环12,对支撑杆6与针筒体1之间进行固定,使得支撑杆6与针筒体1之间的角度不变,再将支撑杆6的一端抵在患者的皮肤表面,实现对入针角度进行调节和定位。When using this device, first turn the
如图1、图2、图3所示,所述针筒体1内部设有活塞头3,所述活塞头3的远离注射针13的一端固定有活塞杆2,所述活塞杆2 伸出针筒体1的外部并连接有推板4;使用本装置时可以通过推动推板4带动活塞杆2向前使得活塞头3同步向前移动,并将针筒体1内的胰岛素通过前方的注射针13注射到患者体内。As shown in Fig. 1, Fig. 2 and Fig. 3, a
如图1、图2、图3所示,所述支撑杆6上远离第一铰接座7的一端固定有支撑垫11,所述针筒体1的外部设有刻度线16;通过设置刻度线16便于医护人员对注射的胰岛素进行定量。As shown in Figure 1, Figure 2 and Figure 3, a
如图1、图2、图3所示,所述针筒体1上位于注射针13的一侧外部设有防护套14,所述防护套14的内部设有橡胶塞15;通过设置防护套14和橡胶塞15可以避免医护人员被注射针13误伤。As shown in Fig. 1, Fig. 2 and Fig. 3, a
尽管已经示出和描述了本实用新型的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本实用新型的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本实用新型的范围由所附权利要求及其等同物限定。Although the embodiments of the present invention have been shown and described, those skilled in the art can understand that various changes and modifications can be made to these embodiments without departing from the principle and spirit of the present invention , replacements and modifications, the scope of the present utility model is defined by the appended claims and their equivalents.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202220354633.2U CN217886692U (en) | 2022-02-22 | 2022-02-22 | Insulin syringe with needle tip protection function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202220354633.2U CN217886692U (en) | 2022-02-22 | 2022-02-22 | Insulin syringe with needle tip protection function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN217886692U true CN217886692U (en) | 2022-11-25 |
Family
ID=84106271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202220354633.2U Expired - Fee Related CN217886692U (en) | 2022-02-22 | 2022-02-22 | Insulin syringe with needle tip protection function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN217886692U (en) |
-
2022
- 2022-02-22 CN CN202220354633.2U patent/CN217886692U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN217886692U (en) | Insulin syringe with needle tip protection function | |
| CN101015717A (en) | Adjustable pulsatile myocardial internal injector | |
| CN111603635A (en) | Professional medical injection instrument | |
| CN212756731U (en) | Insulin syringe | |
| CN216703115U (en) | Insulin injection positioning device | |
| CN218391795U (en) | Anti-puncture insulin injection device | |
| CN201150691Y (en) | Adjustable inner injector for pulsing cardiac muscle | |
| CN213220076U (en) | Insulin injection needle capable of preventing puncture wound | |
| CN221672996U (en) | Fixed auxiliary injection device | |
| CN116492545A (en) | Portable diabetes treatment injection device with wiping disinfection function | |
| CN215608375U (en) | Novel insulin syringe | |
| CN212067365U (en) | Clinical painful anaesthesia device | |
| CN218961490U (en) | Needle special for subcutaneous injection | |
| CN211434532U (en) | Anesthesia device | |
| CN209347174U (en) | A new type of anesthesia syringe | |
| CN215309030U (en) | Special syringe for treating diabetes | |
| CN205434579U (en) | Pancreas transplantation operation is with insulin hypodermic device | |
| CN221332230U (en) | Adjustable insulin syringe | |
| CN222549862U (en) | Insulin injection device | |
| CN216061552U (en) | Self-service injection device for treating diabetes | |
| CN217697519U (en) | Insulin syringe convenient to control liquid medicine injection volume | |
| CN215821978U (en) | Safe taking and placing device for needle cap in insulin pen | |
| CN222398935U (en) | An injection booster | |
| CN217960865U (en) | Telescopic puncture support for medical transfusion port | |
| CN221932757U (en) | An insulin injection device for elderly diabetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20221125 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
